Skip to main content

Digitalis Ventures — Portfolio, Page 3

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

72
Companies
$1.9B
Total invested
$27.6M
Avg. check
41
Industries
Biotechnology 15Health Care 9Medical 8Therapeutics 5Life Science 4Artificial Intelligence (AI) 3+35 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 4972 of 72
Galatea Bio
March 2025

Galatea Bio’s mission is to drive groundbreaking discoveries in healthcare by pairing genetic diversity with cutting-edge data analytics.

Artificial Intelligence (AI) · Miami Lakes$8.0M Series Unknown
Nuvig Therapeutics
December 2024

Nuvig Therapeutics is a biotechnology company developing therapies to induce natural mechanisms to restore immune homeostasis.

Biotechnology · Redwood City$161.0M Series B
Judo Bio
October 2024

Judo Bio is a biotechnology company that develops precision therapeutics targeting specific cell populations to address genetic diseases.

Biotechnology · Cambridge$75.0M Series A
MoeGo
July 2024

MoeGo is a software solution designed for pet care business and professionals.

Mobile Apps · Los Angeles$500K Series Unknown
Rejuvenate Bio
July 2024

Rejuvenate Bio is a biotechnology company that develops therapies to reverse aging and treat age-related diseases.

Biotechnology · San Diego$4.0M Grant
Expressable
May 2024

Expressable is an online speech therapy platform designed for individuals with communication disorders.

E-Learning · Austin$26.0M Series B
Alterome Therapeutics
April 2024

Alterome Therapeutics is a biopharmaceutical company developing alteration-specific targeted therapies.

Biopharma · San Diego$132.0M Series B
Eden Brew
October 2023

Eden Brew is a food and beverage company that provides a range of animal-free and precision-fermented milk and dairy products.

Alternative Protein · Sydney$15.4M Series A
Transcera
July 2023

Transcera is a biotechnology company that uses a new approach to biological drug delivery to transform the treatment of chronic diseases.

Biotechnology · Jamaica PlainSeed
Ascend Gene & Cell Therapies
May 2023

Ascend Gene & Cell Therapies is a model for gene and cell therapy manufacturing.

Biotechnology · Potters Bar$65.9M Series A
Companion
April 2023

Companion is a transformative learning experiences for your dog.

Artificial Intelligence (AI) · San Francisco$6.0M Series Unknown
Bonum Therapeutics
November 2022

Bonum Therapeutics creates a technology platform to treat a wide range of diseases.

Biotechnology · Seattle$93.0M Series A
Elemental Machines
November 2022

Elemental Machines delivers data-driven insights that improves R&D, laboratory operations, and manufacturing outcomes.

Artificial Intelligence (AI) · Cambridge$41.0M Series B
Matchpoint Therapeutics
October 2022

Matchpoint Therapeutics is a biotechnology company that integrates chemoproteomics, ML, and covalent chemistry to treat serious illnesses.

Biotechnology · Cambridge$70.0M Series A
Code Ocean
May 2022

Code Ocean is a computational research platform that aims to help researchers replicate data-heavy science.

Information Services · New York$16.5M Series B
AnimalBiome
April 2022

AnimalBiome is a biotechnology company that creates microbiome restorative supplements to dogs and cats.

Biotechnology · OaklandSeries A
Girihlet
March 2022

Girihlet is a provider of rapid and accurate deep sequencing services with a unique focus on developing novel technologies.

Biotechnology · Brooklyn$500K Debt Financing
BIOMILQ
October 2021

Unlocking human potential with breakthrough mammary biotechnology.

AgTech · Durham$21.0M Series A
Poppins Health
September 2021

Poppins Health provides primary care, prescription drugs, and behavioral health services.

Health Care · Columbus$5.4M Seed
PetMedix
September 2021

PetMedix is a pet therapeutics startup.

Biotechnology · Cambridge$37.2M Series B
SeQure Dx
April 2021

SeQure Dx provides safety data for on and off-target CRISPR gene editing therapies

Biopharma · Waltham$17.5M Series A
Kenzen
January 2021

Kenzen’s Mission is to harness the power of physiology data to predict and prevent industrial workforce injuries and improve productivity.

Analytics · Kansas City$1.0M Corporate Round
MollyBox
November 2019

MollyBox is a subscription-based e-commerce platform for pet-owners.

E-Commerce · Shanghai$13.0M Series B
The Mighty
July 2019

The Mighty is a digital health community created to empower and connect people facing health challenges and disabilities.

Communities · Los Angeles$12.0M Series B

Where Digitalis Ventures invests

Biotechnology15
Health Care9
Medical8
Therapeutics5
Life Science4
Artificial Intelligence (AI)3

About Digitalis Ventures's portfolio

How many companies has Digitalis Ventures invested in?

Digitalis Ventures has invested in 72 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Digitalis Ventures invest in?

Digitalis Ventures's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Life Science. The firm invests across 41 different industry categories.

What is Digitalis Ventures's largest investment?

Among tracked funding rounds, Nuvig Therapeutics received $161.0M in a Series B round. Digitalis Ventures's total known invested capital is $1.9B.

What is the average investment size for Digitalis Ventures?

Digitalis Ventures's average investment size is $27.6M across its portfolio of 72 companies.

What are Digitalis Ventures's most recent investments?

Recent Digitalis Ventures portfolio additions include Galatea Bio, Nuvig Therapeutics, Judo Bio, MoeGo, Rejuvenate Bio. These companies were founded in 2020 or later.

Reach the founders behind these 72 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →